Suzette Matthijsse
Lumanity
Suzette Matthijsse is listed as Lumanity. B2DB records 3 sessions at 1 conference in 2026, most recently ISPOR Europe 2026 (November 2026). Roles on record: moderator 3.
Compiled from published conference agendas; not yet confirmed by Suzette. Is this you? Claim this profile.
About
I am passionate about accelerating patient access to innovative therapies by shaping evidence, strategy, and cross-functional decision-making across the product lifecycle. With 15 years of experience spanning academia and HEOR consulting, I specialize in guiding pharmaceutical and biotech partners through the evolving EU HTAR landscape from early development to Joint Clinical Assessments since the EU HTAR entered into force in 2022.
Sessions at 1 conference
ISPOR Europe 2026 8 November 2026 – 11 November 2026
- First Wave, First Lessons: Multi-Stakeholder Insights from the initial Joint Clinical Assessments Under the European Regulation on Health Technology Assessment Moderator · 9 November 2026
- Navigating Europe’s New Era of Health Policy Reform: How Will the EU HTA Regulation, Pharmaceutical Legislation Revision, Critical Medicines Act, and Biotech Act Shape Medicines Development and Patient Access? Moderator · 9 November 2026
- Preparing Orphan Medicinal Products for JCA: Strengthening the Evidence Package Moderator · 9 November 2026